Evidence map›Paper›PMID 28815472›Full record

ArticleEJNMMI physics2017

Comparison of PET/CT and whole-mount histopathology sections of the human prostate: a new strategy for voxel-wise evaluation.

F Schiller, T Fechter, C Zamboglou, A Chirindel, N Salman, C A Jilg, V Drendel, M Werner, P T Meyer, A-L Grosu and 1 more

Abstract read
In one paragraph

Article in EJNMMI physics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Bioengineering (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Voxel-based comparison of [EJNMMI research · 2020
    Article
  8. Focal dose escalation for prostate cancer usingRadiation oncology (London, England) · 2018
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

F SchillerDepartment of Nuclear Medicine, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
T FechterDepartment of Radiation Oncology, University Medical Center Freiburg, Robert-Koch-Str. 3, 79106, Freiburg, Germany.
C ZamboglouDepartment of Radiation Oncology, University Medical Center Freiburg, Robert-Koch-Str. 3, 79106, Freiburg, Germany.
A ChirindelDepartment of Nuclear Medicine, Claraspital Basel, Kleinriehenstr. 30, 4058, Basel, Switzerland.
N SalmanDepartment of Radiation Oncology, University Medical Center Freiburg, Robert-Koch-Str. 3, 79106, Freiburg, Germany.
C A JilgDepartment of Urology, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
V DrendelDepartment of Pathology, University Medical Center Freiburg, Breisacher Str. 115A, 79106, Freiburg, Germany.
M WernerDepartment of Pathology, University Medical Center Freiburg, Breisacher Str. 115A, 79106, Freiburg, Germany.
P T MeyerDepartment of Nuclear Medicine, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
A-L GrosuDepartment of Radiation Oncology, University Medical Center Freiburg, Robert-Koch-Str. 3, 79106, Freiburg, Germany.
M MixDepartment of Nuclear Medicine, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. michael.mix@uniklinik-freiburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImplementation of PET/CT in diagnosis of primary prostate cancer (PCa) requires a profound knowledge about the tracer, preferably from a quantitative evaluation. Direct visual comparison of PET/CT slices to whole prostate sections is hampered by considerable uncertainties from imperfect coregistration and fundamentally different image modalities. In the current study, we present a novel method for advanced voxel-wise comparison of histopathology from excised prostates to pre-surgical PET. Resected prostates from eight patients who underwent PSMA-PET/CT were scanned (ex vivo CT) and thoroughly pathologically prepared. In vivo and ex vivo CT including histopathology were coregistered with three different methods (manual, semi-/automatic). Spatial overlap after CT-based registration was evaluated with dice similarity (DSC). Furthermore, we constructed 3D cancer distribution models from histopathologic information in various slices. Subsequent smoothing reflected the intrinsically limited spatial resolution of PSMA-PET. The resulting histoPET models were used for quantitative analysis of spatial histopathology-PET pattern agreement focusing on p values and coefficients of determination (R

resultsMean DSC for the three different methods (ManReg, ScalFactReg, and DefReg) were 0.79 ± 0.06, 0.82 ± 0.04, and 0.90 ± 0.02, respectively, while quantification of PET-histopathology pattern agreement after CT-based registration revealed R

conclusionsCreating 3D histoPET models based on thorough histopathological preparation allowed sophisticated quantitative analyses showing highly significant correlations between histopathology and (PSMA-)PET. We recommend manual CT-based coregistration followed by a PET-based MI algorithm to overcome limitations of purely CT-based coregistrations for meaningful voxel-wise comparisons between PET and histopathology.

Indexed as

CoregistrationHistopathologyProstate cancerPSMA PET/CTVoxel-wise

Identifiers

PMID28815472
PMCPMC5559412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.